Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 46Myelodysplastic Syndromes 12Lymphoma 11Leukemia 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Biphenotypic, Acute 9Recurrence 8Leukemia, Lymphocytic, Chronic, B-Cell 7Blast Crisis 7Lymphoma, Mantle-Cell 6Leukemia, Monocytic, Acute 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Hairy Cell 4Waldenstrom Macroglobulinemia 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3Burkitt Lymphoma 3Sarcoma, Myeloid 2Neoplasm, Residual 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Erythroblastic, Acute 2Graft vs Host Disease 2Thrombocythemia, Essential 1Targeted Therapy 1

Interventions

fludarabine phosphate 37Cyclophosphamide 26Mycophenolic Acid 23Whole-Body Irradiation 22Peripheral Blood Stem Cell Transplantation 17Cyclosporine 16fludarabine 13Tacrolimus 13Antilymphocyte Serum 13Rituximab 10Cyclosporins 10Busulfan 10Filgrastim 8Sirolimus 7Methotrexate 7Therapeutics 5Granulocyte Colony-Stimulating Factor 5Cord Blood Stem Cell Transplantation 5ibrutinib 4Melphalan 4Cytarabine 4Allopurinol 4Thiotepa 3Epoetin Alfa 3Darbepoetin alfa 3Alemtuzumab 3thymoglobulin 2pegfilgrastim 2Stem Cell Transplantation 2Radiotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Prolymphocytic × Cladribine × Clear all
NCT00003746 2012-05-15

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Swiss Cancer Institute

Phase 3 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡